Publications by authors named "Lee S Schwartzberg"

100Publications

Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer.

Future Oncol 2020 Nov 19. Epub 2020 Nov 19.

West Cancer Center, 7945 Wolf River Boulevard, Germantown, TN 38138, USA.

View Article and Find Full Text PDF
November 2020

Assessing direct costs of treating metastatic triple-negative breast cancer in the USA.

J Comp Eff Res 2020 Nov 10. Epub 2020 Nov 10.

West Cancer Center, 7945 Wolf Rive Boulevard, Germantown, TN 38138, USA.

View Article and Find Full Text PDF
November 2020

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.

NPJ Precis Oncol 2020 24;4:15. Epub 2020 Jun 24.

Assistance Publique Hôpitaux de Marseille, and Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068, CNRS UMR7258, Aix-Marseille Université, UM105 Marseille, France.

View Article and Find Full Text PDF
June 2020

Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women.

Breast Cancer Res Treat 2020 Jul 23;182(2):247-258. Epub 2020 May 23.

Division of Hematology/Oncology, West Cancer Center/University of Tennessee Health Science Center, 7945 Wolf River Boulevard, Germantown, Memphis, TN, USA.

View Article and Find Full Text PDF
July 2020

Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States.

Ther Adv Med Oncol 2019 14;11:1758835919887044. Epub 2019 Nov 14.

West Cancer Center, 7945 Wolf River Boulevard, Germantown, TN 38183, USA. Division of Hematology/Oncology, Department of Medicine, University of Tennessee Health Science Center, Germantown, TN, USA.

View Article and Find Full Text PDF
November 2019

Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomiting.

J Comp Eff Res 2019 07 9;8(9):657-670. Epub 2019 May 9.

Real World Evidence and Insights, Cardinal Health Specialty Solutions, 7000 Cardinal Place, 4th Floor, Columbus, OH 43017, USA.

View Article and Find Full Text PDF
July 2019

Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting.

Onco Targets Ther 2018 4;11:6459-6478. Epub 2018 Oct 4.

Division of Hematology/Oncology, Department of Medicine, University of Tennessee Health Science Center and West Cancer Center, Memphis, TN, USA.

View Article and Find Full Text PDF
October 2018

Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy.

J Comp Eff Res 2018 12 11;7(12):1161-1170. Epub 2018 Oct 11.

Division of Medical Hematology/Oncology, UPMC Hillman Cancer Center, 5150 Centre Ave, 5th Floor Cancer Pavilion, Pittsburgh, PA 15232, USA.

View Article and Find Full Text PDF
December 2018

Safety of Polysorbate 80 in the Oncology Setting.

Adv Ther 2018 Jun 23;35(6):754-767. Epub 2018 May 23.

Division of Hematology and Oncology, University of Alabama Birmingham, Birmingham, AL, USA.

View Article and Find Full Text PDF
June 2018

Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial.

J Cancer Surviv 2018 08 28;12(4):431-440. Epub 2018 Feb 28.

Department of Preventive Medicine, College of Medicine, University of Tennessee Health Science Center, 66 N. Pauline St., Ste. 633, Memphis, TN, 38163, USA.

View Article and Find Full Text PDF
August 2018

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.

J Clin Oncol 2018 03 26;36(9):884-890. Epub 2018 Jan 26.

Tiffany A. Traina and Ayca Gucalp, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Kathy Miller, Indiana University Simon Cancer Center, Indianapolis, IN; Denise A. Yardley, Tennessee Oncology, Nashville; Lee S. Schwartzberg, The West Clinic, Memphis, TN; Janice Eakle, Florida Cancer Specialists, Fort Myers, FL; Joyce O'Shaughnessy, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology, Dallas, TX; William Gradishar, Northwestern University Feinberg School of Medicine; Rita Nanda, University of Chicago, Chicago; Joyce Steinberg, Astellas Pharma, Northbrook, IL; Peter Schmid, Barts Cancer Institute, Queen Mary University London, London, United Kingdom; Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Catherine Kelly, All Ireland Collaborative Oncology Research Group, Dublin, Ireland; Ahmad Awada, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium; Laura Garcia-Estevez, Centro Integral Oncologico Clara Campal, Hospital Madrid Norte-Sanchinarro; Javier Cortes, Ramon y Cajal University Hospital, Madrid, and, Vall d'Hebron Institute of Oncology and Baselga Oncological Institute, Barcelona, Spain; Maureen E. Trudeau, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; and Hirdesh Uppal, Amy Peterson, and Iulia Cristina Tudor, Medivation, San Francisco, CA.

View Article and Find Full Text PDF
March 2018

Chemotherapy-induced nausea and vomiting: strategies for prevention and treatment.

Clin Adv Hematol Oncol 2017 Dec;15(12):906-913

The University of Tennessee Health Science Center, Memphis, Tennessee.

View Article and Find Full Text PDF
December 2017

Expanding the search for significant EGFR mutations in NSCLC outside of the tyrosine kinase domain with next-generation sequencing.

Med Oncol 2017 Jul 1;34(7):126. Epub 2017 Jun 1.

Department of Internal Medicine, The University of Tennessee Health Science Center, 956 Court Ave., Suite H314, Memphis, TN, 38163, USA.

View Article and Find Full Text PDF
July 2017

Use of Biomarkers and Multigene Assays in Breast Cancer.

J Natl Compr Canc Netw 2017 05;15(5S):676-678

Presented by Lee S. Schwartzberg, MD, West Cancer Center, and Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, Tennessee.

View Article and Find Full Text PDF
May 2017

Collaborative Management of Patients With Estrogen Receptor-Positive Breast Cancer.

J Adv Pract Oncol 2017 Apr 1;8(3):250-254. Epub 2017 Apr 1.

West Cancer Center, Memphis, Tennessee.

View Article and Find Full Text PDF
April 2017

Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer.

J Natl Compr Canc Netw 2017 03;15(3):284-287

From the University of Tennessee West Cancer Center, Germantown, Tennessee.

View Article and Find Full Text PDF
March 2017

Highlights in CINV from the 2016 MASCC/ISOO annual meeting: Commentary.

Clin Adv Hematol Oncol 2016 Aug;14 Suppl 10(8):20-23

The University of Tennessee Health Science Center, Memphis, Tennessee.

View Article and Find Full Text PDF
August 2016

Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.

Anticancer Res 2016 Aug;36(8):4033-8

Department of Hematology/Oncology, The West Cancer Center, The University of Tennessee Health Science Center, Memphis, TN, U.S.A.

View Article and Find Full Text PDF
August 2016

Strategies for the Management of Early-Stage Breast Cancer in Older Women.

J Natl Compr Canc Netw 2016 05;14(5 Suppl):647-50

Presented by Lee S. Schwartzberg, MD, The University of Tennessee Health Science Center, West Cancer Center, Memphis, Tennessee, and Sarah L. Blair, MD, Department of Surgery, University of California San Diego Moores Cancer Center, La Jolla, California.

View Article and Find Full Text PDF
May 2016

Advances in the Management of Chemotherapy-Induced Nausea and Vomiting: New Data From Recent and Ongoing Trials.

Clin Adv Hematol Oncol 2015 Oct;13(10 Suppl 10):1-14

University of California, San Diego Moores Cancer Center, La Jolla, California.

View Article and Find Full Text PDF
October 2015

15 years of The Lancet Oncology.

Lancet Oncol 2015 Dec;16(16):1588-91

The West Clinic, Memphis, TN 38120, USA. Electronic address:

View Article and Find Full Text PDF
December 2015

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

J Natl Compr Canc Netw 2015 Dec;13(12):1475-85

From Robert H. Lurie Comprehensive Cancer Center of Northwestern University; University of Washington/Seattle Cancer Care Alliance; UCSF Helen Diller Family Comprehensive Cancer Center; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; University of Colorado Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; University of Alabama at Birmingham Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Mayo Clinic Cancer Center; Fox Chase Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts General Hospital Cancer Center; Duke Cancer Institute; Vanderbilt-Ingram Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center; Roswell Park Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Research Advocacy Network; Moffitt Cancer Center; City of Hope Comprehensive Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; and National Comprehensive Cancer Network.

View Article and Find Full Text PDF
December 2015

NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys.

J Natl Compr Canc Netw 2015 Nov;13(11):1337-46

From UC San Diego Moores Cancer Center, San Diego, California; Stanford Cancer Institute, Stanford, California; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, Ohio; Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Washington University, St. Louis, Missouri; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; City of Hope Comprehensive Cancer Center, Los Angeles, California; The West Clinic, Memphis, Tennessee; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California; Johns Hopkins University School of Medicine, Baltimore, Maryland; and Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

View Article and Find Full Text PDF
November 2015

New and emerging therapeutic options for the management of chemotherapy-induced nausea and vomiting.

Clin Adv Hematol Oncol 2015 Mar;13(3 Suppl 3):3-13, 1; quiz 2 p following 14

The University of Tennessee Health Science Center, Memphis, Tennessee.

View Article and Find Full Text PDF
March 2015

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.

J Clin Oncol 2015 May 16;33(14):1574-83. Epub 2015 Mar 16.

Karen A. Gelmon, David G. Huntsman, and Samuel Aparicio, British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver; Susan L. Ellard, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, British Columbia; Julie Lemieux, Centre Hospitalier Affilié Hopital Du St Sacrement, Quebec City, Quebec; Lois E. Shepherd, Dora Nomikos, Judith-Anne W. Chapman, and Wendy R. Parulekar, NCIC Clinical Trials Group, Queen's University, Kingston; Susan Dent, Ottawa Health Research Institute, Ottawa; Kathleen I. Pritchard, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto; Timothy J. Whelan, Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario; Katia Tonkin, Cross Cancer Institute, Edmonton, Alberta, Canada; Frances M. Boyle, Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia; Bella Kaufman, Sheba Medical Centre, Tel Hashomer; Shulamith Rizel, Rabin Medical Center, Petach Tikva, Israel; Alexey Manikhas, City Clinical Oncological Dispensery, St Petersburg; Sergei Tjulandin, Russian Cancer Research Center, Moscow; Rustem Khasanov, Clinical Oncology Dispensary, Kazan, Russia; Angelo Di Leo, Sandro Pitgliani Medical Oncology Unit, Prato, Italy; Miguel Martin, Servicio Oncologia Hospital Gregorio Marañon, Madrid, Spain; Lee S. Schwartzberg, West Clinic, Memphis, TN; Arnd Nusch, Praxis, Velbert, Germany; Robert E. Coleman, Weston Park Hospital, Cancer Research Centre, Sheffield, United Kingdom; Hirofumi Mukai, National Cancer Center Hospital East, Kashiwa-shi, Japan; Anne P. Connor, GlaxoSmithKline, Collegeville, PA; and Sergio L. Santillana, GlaxoSmithKline, Rio de Janeiro, Brazil.

View Article and Find Full Text PDF
May 2015

A review of rapid-onset opioids for breakthrough pain in patients with cancer.

J Opioid Manag 2014 May-Jun;10(3):207-15

The University of Tennessee Health Science Center, Memphis, Tennessee; Medical Director for The West Clinic, Memphis, Tennessee.

View Article and Find Full Text PDF
September 2014

PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.

J Clin Oncol 2014 Jul 31;32(21):2240-7. Epub 2014 Mar 31.

Lee S. Schwartzberg, West Clinic, Memphis, TN; Fernando Rivera, Hospital Universitario Marques de Valdecilla, Santander, Spain; Meinolf Karthaus, Städtisches Klinikum München, Klinikum Neuperlach, Munich, Germany; Gianpiero Fasola, University Hospital Santa Maria della Misericordia, Udine, Italy; Jean-Luc Canon, Grand Hopital de Charleroi, Charleroi, Belgium; J. Randolph Hecht, David Geffen School of Medicine at University of California Los Angeles, Los Angeles; and Hua Yu, Kelly S. Oliner, and William Y. Go, Amgen, Thousand Oaks, CA.

View Article and Find Full Text PDF
July 2014

Phase I dosage finding and pharmacokinetic study of intravenous topotecan and oral erlotinib in adults with refractory solid tumors.

Cancer Chemother Pharmacol 2014 Mar 22;73(3):561-8. Epub 2014 Jan 22.

Department of Pharmaceutical Sciences, MS 313, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA,

View Article and Find Full Text PDF
March 2014

Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer.

J Thorac Oncol 2013 Oct;8(10):1308-16

*University of Texas Southwestern, Dallas, Texas; †ACORN and West Clinic, Memphis, Tennessee; ‡Cancer Center of Kansas, Wichita, Kansas; §UCLA/Translational Oncology Research International Network, Los Angeles, Los Angeles; ‖Alamance Regional Medical Center, Burlington, North Carolina; ¶Washington University, St. Louis, Missouri; and #Lilly USA, LLC, Indianapolis, Indiana.

View Article and Find Full Text PDF
October 2013

Recent advances and updated guidelines in the management of chemotherapy-induced nausea and vomiting.

Clin Adv Hematol Oncol 2011 Nov;9(11 Suppl 27):1-14; quiz 15-6

The West Clinic, Memphis, Tennessee, USA.

View Article and Find Full Text PDF
November 2011

Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.

Clin Adv Hematol Oncol 2011 Jan;9(1):suppl 1-15

Thoracic Oncology Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article and Find Full Text PDF
January 2011

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies.

J Oncol Pract 2010 May;6(3):133-40

Sarah Cannon Research Institute, Nashville; West Clinic, Memphis, TN; Penn State Cancer Institute, Hershey, PA; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH; M. D. Anderson Cancer Center at Orlando, Orlando, FL; North County Oncology Medical Clinic, Oceanside; Amgen, Thousand Oaks; and Ida M. and Cecil H. Green Cancer Center, Scripps Clinic, La Jolla, CA.

View Article and Find Full Text PDF
May 2010

Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium.

Clin Adv Hematol Oncol 2010 May;8(5 Suppl 9):1-16

Community Clinical Oncology Program Research Base Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA.

View Article and Find Full Text PDF
May 2010